Rating History for Watson Pharmaceuticals (WPI) by Goldman Sachs
| Date | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/11/2013 | Downgrade | Neutral (Buy) |
96.00 (100.00) |
87.99 | 85.73 | -2.57% | Details |
| 9/11/2012 | Downgrade | Buy (Conviction Buy) |
95.00 (90.00) |
83.59 | 87.99 | 5.26% | Details |
| 6/19/2012 | Upgrade | Conviction Buy (Buy) |
87.00 (N/A) |
69.22 | 83.59 | 20.76% | Details |
| 1/27/2012 | Maintain | Buy (N/A) |
68.00 (N/A) |
Details | |||
| 1/23/2012 | Maintain | Conviction Buy (N/A) |
70.00 (N/A) |
Details | |||
| 10/31/2011 | Maintain | Conviction Buy (N/A) |
83.00 (N/A) |
Details | |||
| 9/22/2011 | New Coverage | Conviction Buy (N/A) |
85.00 (N/A) |
70.04 | 69.22 | -1.17% | Details |
